Kindred Biosciences, Inc. KIN

Kindred Biosciences, Inc. DIO Ratio 2011-2026 | KIN

Annual DIO Ratio Kindred Biosciences, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16.3	2.62 K	4.02 K	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
4.02 K	16.3	2.22 K

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Aptorum Group Limited APM	4.89	$ 1.06	-0.93 %	$ 5.78 M	China
Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
Biogen BIIB	394	$ 187.4	0.75 %	$ 27.3 B	USA
Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
BioXcel Therapeutics BTAI	227	$ 1.98	-1.0 %	$ 5.02 M	USA
CASI Pharmaceuticals CASI	47.4	$ 1.04	-2.34 %	$ 142 M	USA
Catalyst Biosciences CBIO	410	$ 10.74	-2.1 %	$ 707 M	USA
Arena Pharmaceuticals ARNA	160	-	-6.81 %	$ 3.04 B	USA
Cellectis S.A. CLLS	23.3	$ 4.42	-1.34 %	$ 116 M	France
Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
Amphastar Pharmaceuticals AMPH	132	$ 27.75	0.02 %	$ 1.34 B	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	239	$ 11.13	-2.02 %	$ 720 M	USA
BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
Axon Enterprise AXON	116	$ 633.45	3.34 %	$ 48 B	USA
Aytu BioScience AYTU	209	$ 2.64	-0.75 %	$ 16.6 M	USA
BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
AstraZeneca PLC AZN	206	$ 94.65	0.68 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA